Revenue
2022
2023
2024
2025
Revelation Biosciences, Inc. (REVB)
Price$0.99945Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2021
2024
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — |
| Research & development | $4.1M | $3.5M | $4.1M | $5.4M | $6.9M | — | — |
| Operating expenses | $9.1M | $8.0M | $8.7M | $10.9M | $12.0M | $145,492 | — |
| Operating income | −$9.1M | −$8.0M | −$8.7M | −$10.9M | −$12.0M | — | — |
| EBITDA | −$9.0M | −$7.9M | −$8.6M | −$10.8M | −$11.9M | — | — |
| Net income | −$8.9M | −$15.0M | −$120,254 | −$10.8M | −$12.0M | −$1.6M | −$3,638 |
| Basic EPSper basic share | -$23.95 | -$1,052.16 | -$12,276,363.64 | -$5,787,151,515,151.52 | -$183,164,983,164,983,200.00 | -$3,256,266,367,377,479,700.00 | — |
| Diluted EPSper diluted share | -$23.95 | -$1,052.16 | -$12,276,363.64 | -$5,787,151,515,151.52 | -$183,164,983,164,983,200.00 | -$3,256,266,367,377,479,700.00 | — |
Owners
Reported shareholders
≈5.49%of listed shares
Rolke James214.74K shares · Apr 30, 2026
View holders
| Holder | % owned |
|---|---|
Rolke James | ≈5.49%214.74K shares |
SABBY MANAGEMENT, LLC | 5.39%210.58K shares |
Zygmont Chester Stanley III | ≈2.36%92.07K shares |
CITADEL ADVISORS LLC | 0.99%38.58K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.44%17.19K shares |
HRT FINANCIAL LP | 0.43%16.98K shares |
VANGUARD FIDUCIARY TRUST CO | 0.34%13.13K shares |
ROPER JESS | —12.83K shares |
CARVER JENNIFER | —12.76K shares |
Chawla Lakhmir S | —12.16K shares |
Tower Research Capital LLC (TRC) | 0.17%6.53K shares |
ROYAL BANK OF CANADA | 0.02%747 shares |
SBI Securities Co., Ltd. | <0.01%344 shares |
BARCLAYS PLC | <0.01%168 shares |
BNP PARIBAS ASSET MANAGEMENT Holding S.A. | <0.01%9 shares |
Caitong International Asset Management Co., Ltd | <0.01%1 shares |
TIDMARSH GEORGE F | —— shares |
Percentages use 3.91M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data